Clinical trial
Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)
NCT00228423 · Ottawa Heart Institute Research Corporation, Other · Completed
Key facts
| NCT number | NCT00228423 |
|---|---|
| Title | Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial) |
| Official title | Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass? |
| Acronym | CASCADE |
| Lead sponsor | Ottawa Heart Institute Research Corporation, Other |
| Collaborators | Sanofi Industry Bristol-Myers Squibb |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | Clopidogrel 75 mg daily, water pill daily |
| Enrollment | 113 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Sep 28, 2005 |
| Last update posted | Apr 27, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: